Interro IQ

The AI-powered flow cytometry standard transforming biomarker discovery, unlocking a $5.7 billion market. Interro IQ's Universal Immunophenotyping Screen combines AI-enabled flow cytometry with standardization to rapidly identify clinically useful biomarkers. Disease-agnostic and scalable, the UIS delivers results in weeks, making equivalent 2 year timelines feasible in 2-8 weeks.